Hana Pharm Co Ltd (293480) — Capital Reinvestment Ratio
Hana Pharm Co Ltd (293480) has a Capital Reinvestment Ratio of 42.57x as of June 2025, meaning it reinvests 43% of its operating cash flow (₩235.15 Million) in capital expenditures (₩10.01 Billion). Check tangible equity quality of Hana Pharm Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hana Pharm Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Hana Pharm Co Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Hana Pharm Co Ltd generate cash.
Annual Capital Reinvestment Ratio for Hana Pharm Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Hana Pharm Co Ltd from 2016 to 2024. See Hana Pharm Co Ltd (293480) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.52x | ₩25.30 Billion | ₩13.21 Billion | ▼ -34.6% |
| 2023 | 0.80x | ₩18.40 Billion | ₩14.68 Billion | ▼ -31.1% |
| 2022 | 1.16x | ₩30.88 Billion | ₩35.77 Billion | ▼ -14.6% |
| 2021 | 1.36x | ₩25.66 Billion | ₩34.81 Billion | ▲ +23.3% |
| 2020 | 1.10x | ₩15.58 Billion | ₩17.14 Billion | ▲ +3.4% |
| 2019 | 1.06x | ₩31.72 Billion | ₩33.73 Billion | ▲ +426.7% |
| 2018 | 0.20x | ₩27.59 Billion | ₩5.57 Billion | ▼ -49.7% |
| 2017 | 0.40x | ₩25.38 Billion | ₩10.19 Billion | ▼ -39.8% |
| 2016 | 0.67x | ₩12.46 Billion | ₩8.31 Billion | — |